基于CiteSpace的内皮祖细胞在再生领域的文献计量可视化分析

宏杰 苏(广西壮族自治区糖尿病足保肢工程研究中心，中国；广西壮族自治区糖尿病足保肢工程研究中心，中国；广西医科大学再生医学研究中心，中国)
杰 刘(广西壮族自治区糖尿病足保肢工程研究中心，中国；广西医科大学再生医学与医用生物资源开发应用协同创新中心，中国；广西医科大学再生医学研究中心，中国)
俊 侯(广西壮族自治区糖尿病足保肢工程研究中心，中国；广西壮族自治区糖尿病足保肢工程研究中心，中国；广西医科大学再生医学研究中心，中国)
凯兵 刘(广西医科大学再生医学研究中心，中国；广西壮族自治区糖尿病足保肢工程研究中心，中国)
文聪 覃(广西壮族自治区糖尿病足保肢工程研究中心，中国；广西壮族自治区糖尿病足保肢工程研究中心，中国)
奇凯 花(广西壮族自治区糖尿病足保肢工程研究中心，中国；广西壮族自治区糖尿病足保肢工程研究中心，中国；广西医科大学再生医学与医用生物资源开发应用协同创新中心，中国； 广西医科大学再生医学研究中心，中国)

摘要

背景： 内皮祖细胞近年来在疾病的研究和治疗应用中扮演了重要角色。然而在这一领域仅有少量的文献计量学分析。论文旨在通过可视化分析内皮祖细胞在再生领域的研究热点和趋势。 方法： 检索Web of Science Core Collection数据库自2001年至2021年间的所有以 “内皮祖细胞”和“再生”为主题词组合的检索。通过CiteSpace和VOSviewer软件进行分析处理。 结果： 收集论著共计2587篇。有关内皮祖细胞在再生领域的研究逐年增加，这些出版物主要来自于以中国和美国为首的98个国家和494个机构。我们选定了832位作者进行分析。其中， Asahara Takayuki文章数量最显著且文献被引数量最多。被引用次数最多的期刊是《美国国家科学院院刊》。节点度最高的关键词是Angiogenesis。 结论： 内皮祖细胞在再生领域的研究正在蓬勃发展。要加强国家和机构之间的合作与交流。以促进内皮祖细胞的基础应用向临床转化。

关键词

内皮祖细胞，文献计量学，再生医学，数据可视化

参考

ASAHARA T, MUROHARA T, SULLIVAN A, et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis[J]. Science, 1997,275(5302): 964-966.

BAKER C D, BALASUBRAMANIAM V, MOURANI P M, et al. Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia[J]. European Respiratory Journal, 2012,40(6): 1516.

CHEN C, IBEKWE-SANJUAN F, HOU J. The structure and dynamics of cocitation clusters: A multiple-perspective cocitation analysis[J]. Journal of the American Society for Information Science and Technology, 2010,61(7): 1386-1409.

CHEN C. Searching for intellectual turning points: Progressive knowledge domain visualization[J]. Proceedings of the National Academy of Sciences, 2004,101(suppl 1): 5303.

CHEN C. Science Mapping: A Systematic Review of the Literature[J]. Journal of Data and Information Science, 2017,2(2): 1-40.

CHEN C, HU Z, LIU S, et al. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace[J]. Expert Opinion on Biological Therapy, 2012,12(5): 593-608.

KWON S, EGUCHI M, WADA M, et al. Specific Jagged-1 Signal From Bone Marrow Microenvironment Is Required for Endothelial Progenitor Cell Development for Neovascularization[J]. Circulation, 2008,118(2): 157-165.

SCHACHINGER VOLKER, ERBS SANDRA, ELSASSER ALBRECHT, et al. Intracoronary Bone Marrow-derived Progenitor Cells in Acute Myocardial Infarction[J]. New England Journal of Medicine, 2006,355(12): 1210-1221.

KWON S, LEE Y, YOKOYAMA A, et al. Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization[J]. Journal of Molecular and Cellular Cardiology, 2011,51(3): 308-317.

KAWAMOTO ATSUHIKO, KATAYAMA MINAKO, HANDA NOBUHIRO, et al. Intramuscular Transplantation of G‐CSF‐Mobilized CD34+ Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single-Blinded, Dose-Escalation Clinical Trial[J]. Stem Cells, 2009,27(11): 2857-2864.

FADINI G P, LOSORDO D, DIMMELER S. Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use[J]. Circulation Research, 2012,110(4): 624-637.

KAWAMOTO A, GWON H, IWAGURO H, et al. Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia[J]. Circulation, 2001,103(5): 634-637.

URBICH C, DIMMELER S. Endothelial Progenitor Cells: Characterization and Role in Vascular Biology[J]. circulation research, 2004,95(4): 343-353.

ORLIC D, KAJSTURA J, CHIMENTI S, et al. Bone marrow cells regenerate infarcted myocardium[J]. nature, 2001,410(6829): 701-705.

ASSMUS B, SCHÄCHINGER V, TEUPE C, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)[J]. Circulation, 2002,106(24): 3009-3017.

TEPPER O M, GALIANO R D, CAPLA J M, et al. Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures[J]. circulation, 2002,106(22): 2781-2786.

MURRY C E, SOONPAA M H, REINECKE H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts[J]. Nature, 2004,428(6983): 664-668.

KOCHER A. A., SCHUSTER M. D., SZABOLCS M. J., 等. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function[J]. Nature Medicine, 2001,7(4): 430-436.

WOLLERT K C, MEYER G P, LOTZ J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial[J]. The Lancet, 2004,364(9429): 141-148.

JACKSON K A, MAJKA S M, WANG H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells[J]. The Journal of Clinical Investigation, 2001,107(11): 1395-1402.

REHMAN JALEES, LI JINGLING, ORSCHELL CHRISTIE M, et al. Peripheral Blood-Endothelial Progenitor Cells ?Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors[J]. Circulation, 2003,107(8): 1164-1169.

WERNER N, KOSIOL S, SCHIEGL T, et al. Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes[J]. New England Journal of Medicine, 2005,353(10): 999-1007.

RAFII S, LYDEN D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration[J]. Nature Medicine, 2003,9(6): 702-712.

SCHACHINGER V, ASSMUS B, BRITTEN M B, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial[J]. Journal of the American College of Cardiology, 2004,44(8): 1690-1699.

KAWAMOTO A, GWON H, IWAGURO H, et al. Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia[J]. Circulation, 2001,103(5): 634-637.

WANG C, LIN G, LUAN Y, et al. HIF-prolyl hydroxylase 2 silencing using siRNA delivered by MRI-visible nanoparticles improves therapy efficacy of transplanted EPCs for ischemic stroke[J]. Biomaterials, 2019,197: 229-243.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v5i1.10179